Prague, Czechia

Josef Hajicek

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Praha, CZ (2009)
  • Praha 2, CZ (2009)
  • Prague, CZ (2010)

Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Josef Hajicek

Introduction

Josef Hajicek is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of chemistry, particularly in the development of methods related to pharmaceutical compounds. With a total of four patents to his name, Hajicek's work has had a considerable impact on the industry.

Latest Patents

Hajicek's latest patents include a method of racemization of the R(−) isomer of the (2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester. This innovative process involves converting a portion of the R(−) isomer to the S(+) isomer in the presence of specific organic solvents and bases. Another significant patent is for the manufacturing of crystalline form I of clopidogrel hydrogen sulphate. This method details the separation of clopidogrel from a solution in various solvents, showcasing Hajicek's expertise in pharmaceutical manufacturing.

Career Highlights

Throughout his career, Hajicek has worked with prominent companies such as Zentiva K.s. and Zentiva A.s. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects in the pharmaceutical sector.

Collaborations

Hajicek has collaborated with notable colleagues, including Hana Stepankova and Miroslav Veverka. These partnerships have facilitated the exchange of ideas and advancements in their respective fields.

Conclusion

Josef Hajicek's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents and collaborations reflect his dedication to advancing scientific knowledge and improving pharmaceutical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…